LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 1 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 1. - Dataset (ID:20309)

 Full screen view
Filter results: >>>>
Cell Small Molecule Small Mol Concentration (uM) Time Point (hr) Total Cell Count Before Treatment Total Cell Count After Treatment Total Control Cell Count Relative Cell Count Normalized Growth Rate Inhibition Value Assay Plate Assay Well
MCF 10A-H2B-mCherry Trametinib
0.00033333
 38.95 770.25 4563 4543 1.0042 1.0033
MN20160304_L02
E21
MCF 10A-H2B-mCherry Trametinib
0.00033333
 41.17 770.25 4272 5010 0.8526 0.8854
MN20160304_L02
E16
MCF 10A-H2B-mCherry Trametinib
0.00033333
 41.17 770.25 5021 5010 1.0021 1.0015
MN20160304_L02
E21
MCF 10A-H2B-mCherry Trametinib
0.00033333
 43.39 770.25 4604 5404 0.8519 0.8891
MN20160304_L02
E16
MCF 10A-H2B-mCherry Trametinib
0.00033333
 43.39 770.25 5502 5404 1.0181 1.0128
MN20160304_L02
E21
MCF 10A-H2B-mCherry Trametinib
0.00033333
 45.61 770.25 4945 5813 0.8507 0.8921
MN20160304_L02
E16
MCF 10A-H2B-mCherry Trametinib
0.00033333
 45.61 770.25 5866 5813 1.0091 1.0062
MN20160304_L02
E21
MCF 10A-H2B-mCherry Trametinib
0.00033333
 47.83 770.25 5363 6223 0.8617 0.9037
MN20160304_L02
E16
MCF 10A-H2B-mCherry Trametinib
0.00033333
 47.83 770.25 6155 6223 0.9890 0.9927
MN20160304_L02
E21
MCF 10A-H2B-mCherry Trametinib
0.00033333
 50.05 770.25 5805 6629 0.8756 0.9163
MN20160304_L02
E16
MCF 10A-H2B-mCherry Trametinib
0.00033333
 50.05 770.25 6726 6629 1.0146 1.0093
MN20160304_L02
E21
MCF 10A-H2B-mCherry Trametinib
0.00033333
 52.27 770.25 6397 7058 0.9062 0.9393
MN20160304_L02
E16
MCF 10A-H2B-mCherry Trametinib
0.00033333
 52.27 770.25 7279 7058 1.0312 1.0193
MN20160304_L02
E21
MCF 10A-H2B-mCherry Trametinib
0.00033333
 54.49 770.25 6861 7555 0.9081 0.9423
MN20160304_L02
E16
MCF 10A-H2B-mCherry Trametinib
0.00033333
 54.49 770.25 7802 7555 1.0326 1.0196
MN20160304_L02
E21
MCF 10A-H2B-mCherry Trametinib
0.00033333
 56.71 770.25 7268 8001 0.9083 0.9439
MN20160304_L02
E16
MCF 10A-H2B-mCherry Trametinib
0.00033333
 56.71 770.25 8307 8001 1.0382 1.0223
MN20160304_L02
E21
MCF 10A-H2B-mCherry Trametinib
0.00033333
 58.94 770.25 7798 8444 0.9235 0.9544
MN20160304_L02
E16
MCF 10A-H2B-mCherry Trametinib
0.00033333
 58.94 770.25 8913 8444 1.0555 1.0315
MN20160304_L02
E21
MCF 10A-H2B-mCherry Trametinib
0.00033333
 61.16 770.25 8230 8892 0.9256 0.9566
MN20160304_L02
E16
MCF 10A-H2B-mCherry Trametinib
0.00033333
 61.16 770.25 9431 8892 1.0606 1.0336
MN20160304_L02
E21
MCF 10A-H2B-mCherry Trametinib
0.00033333
 63.39 770.25 8636 9326 0.9260 0.9577
MN20160304_L02
E16
MCF 10A-H2B-mCherry Trametinib
0.00033333
 63.39 770.25 9853 9326 1.0565 1.0308
MN20160304_L02
E21
MCF 10A-H2B-mCherry Trametinib
0.00033333
 65.61 770.25 9125 9736 0.9372 0.9649
MN20160304_L02
E16
MCF 10A-H2B-mCherry Trametinib
0.00033333
 65.61 770.25 10194 9736 1.0470 1.0253
MN20160304_L02
E21